Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
- USD | -.--% | +1.51% | +0.58% |
May. 13 | Morgan Stanley Lowers Price Target on Organogenesis Holdings to $3 From $3.50, Keeps Equalweight Rating | MT |
May. 10 | Health Care Edges Higher Amid Rotation to Utilities - Health Care Roundup | DJ |
Chart calendar Organogenesis Holdings Inc.
Upcoming events on Organogenesis Holdings Inc.
Past events on Organogenesis Holdings Inc.
2024-05-09 05:00 pm | Q1 2024 Earnings Call |
2024-05-09 04:05 pm | Q1 2024 Earnings Release |
2024-02-29 05:00 pm | Q4 2023 Earnings Call |
2024-02-29 04:05 pm | Q4 2023 Earnings Release |
2024-02-13 | BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference |
2023-11-09 05:00 pm | Q3 2023 Earnings Call |
2023-11-09 04:05 pm | Q3 2023 Earnings Release |
2023-09-11 08:00 am | Morgan Stanley Global Healthcare Conference |
2023-08-09 05:00 pm | Q2 2023 Earnings Call |
2023-08-09 04:05 pm | Q2 2023 Earnings Release |
2023-06-13 11:00 am | Annual General Meeting |
2023-05-10 05:00 pm | Q1 2023 Earnings Call |
2023-05-10 04:05 pm | Q1 2023 Earnings Release |
2023-03-01 05:00 pm | Q4 2022 Earnings Call |
2023-03-01 04:02 pm | Q4 2022 Earnings Release |
2022-12-07 | Cantor Fitzgerald Medical & Aesthetic Dermatology, Ophthalmology & MedTech Conference |
2022-11-09 05:00 pm | Q3 2022 Earnings Call |
2022-11-09 04:05 pm | Q3 2022 Earnings Release |
2022-09-13 11:45 am | Morgan Stanley Global Healthcare Conference |
2022-08-09 05:00 pm | Interim 2022 Earnings Call |
Annual results
Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 261 258 1.2% | 338 337 0.46% | 468 464 0.9% | 451 0,00 - | 433 442 -1.94% | 456 |
EBITDA Million USD | Released Forecast Spread | -18,2 -23,2 21.75% | 36,9 32,9 12.2% | 89,1 82,7 7.79% | 49,3 52,6 -6.33% | 42,6 34,9 22.24% | 26,9 |
EBIT Million USD | Released Forecast Spread | -29,5 -34,4 14.47% | 27,4 22,0 24.77% | 72,9 68,6 6.29% | 22,3 0,00 - | 12,5 15,9 -21.39% | -1,22 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -40,3 -44,9 10.23% | 18,5 12,8 43.99% | 63,8 59,0 8.11% | 20,3 22,4 -9.46% | 10,4 13,8 -24.86% | -3,52 |
Net income Million USD | Released Forecast Spread | -41,1 -45,1 8.97% | 17,9 13,3 34.65% | 94,9 55,9 69.85% | 15,5 15,9 -2.31% | 4,95 6,23 -20.6% | -1,55 |
EPS USD | Released Forecast Spread | -0,44 -0,49 10.16% | 0,16 0,12 39.13% | 0,71 0,42 71.08% | 0,12 0,12 0% | 0,04 0,05 -14.29% | -0,01 |
Announcement Date | 09/03/20 | 16/03/21 | 01/03/22 | 01/03/23 | 29/02/24 | - |
Quarterly results
Fiscal Period | December | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 98,1 95,7 2.53% | 121 121 0.41% | 117 121 -3.3% | 116 122 -5.62% | 108 95,5 12.71% | 117 115 1.93% | 109 111 -2.58% | 99,7 109 -8.62% | 110 100 9.72% | 123 | 115 | 110 | 115 | 127 |
EBITDA Million USD | Released Forecast Spread | 5,00 15,2 -66.97% | 18,6 21,5 -13.5% | 11,6 16,5 -29.67% | 14,1 17,4 -19.17% | 3,77 3,60 4.67% | 15,4 14,6 5.5% | 16,0 7,70 107.4% | 7,47 7,60 -1.67% | 2,55 -0,10 2651% | 7,30 | 7,60 | 9,40 | 8,70 | 12,8 |
EBIT Million USD | Released Forecast Spread | 0,87 7,15 -87.8% | 11,9 15,2 -21.22% | 1,78 11,8 -84.92% | 8,72 10,4 -16.17% | -4,00 -2,40 -66.71% | 9,75 7,60 28.22% | 8,05 0,70 1050% | -1,27 4,00 -131.73% | -3,85 -5,30 27.32% | 0,90 | 0,80 | 2,20 | 1,70 | 6,40 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 0,13 6,25 -97.89% | 11,2 14,3 -21.79% | 1,21 10,9 -88.88% | 8,75 9,80 -10.67% | -4,63 -3,70 -25.05% | 9,18 6,30 45.7% | 7,64 -0,60 1372.83% | -1,80 3,50 -151.31% | -4,34 -5,80 25.12% | 0,40 | 0,30 | 1,70 | 1,20 | 5,90 |
Net income Million USD | Released Forecast Spread | 0,09 6,95 -98.75% | 8,74 10,8 -18.66% | 0,22 7,85 -97.26% | 7,49 6,90 8.49% | -2,97 -2,60 -14.19% | 5,32 3,50 51.89% | 3,17 -0,40 891.75% | -0,57 1,45 -139.17% | -2,10 -3,60 41.67% | 0,65 | -0,10 | 0,90 | 0,90 | 4,30 |
EPS USD | Released Forecast Spread | 0,00 0,05 - | 0,07 0,08 -12.5% | 0,00 0,06 - | 0,06 0,05 20% | -0,02 -0,02 0% | 0,04 0,03 60% | 0,02 0,01 300% | 0,00 0,00 - | -0,02 -0,03 25.01% | 0,00 | 0,00 | 0,01 | 0,00 | 0,01 |
Announcement Date | 10/05/22 | 09/08/22 | 09/11/22 | 01/03/23 | 10/05/23 | 09/08/23 | 09/11/23 | 29/02/24 | 09/05/24 | - | - | - | - | - |
2024-07-15 01:45 am | ADDLIFE AB: Q2 2024 Earnings Release |
2024-07-21 | MEDPACE HOLDINGS, INC.: Q2 2024 Earnings Release (Projected) |
2024-07-23 | SYNGENE INTERNATIONAL LIMITED: Q1 2025 Earnings Release (Projected) |
2024-07-23 | ALKERMES PLC: Q2 2024 Earnings Release (Projected) |
2024-07-23 | IQVIA HOLDINGS INC.: Q2 2024 Earnings Release (Projected) |
2024-07-23 | ICON PUBLIC LIMITED COMPANY: Q2 2024 Earnings Release (Projected) |
2024-07-24 | LONZA GROUP AG: Q2 2024 Earnings Release |
2024-07-25 01:00 am | BACHEM HOLDING AG: Q2 2024 Earnings Release |
2024-07-25 | PHARVARIS N.V.: Q2 2024 Earnings Release (Projected) |
2024-07-26 01:00 am | BB BIOTECH AG: Q2 2024 Earnings Release |
Past sector events for Organogenesis Holdings Inc.
2024-05-29 04:01 pm | IMMUNOVANT, INC.: Q4 2024 Earnings Release |
2024-05-23 07:00 am | CUREVAC N.V.: Q1 2024 Earnings Release |
2024-05-22 01:00 am | EVOTEC SE: Q1 2024 Earnings Release |
2024-05-21 05:14 pm | ALVOTECH: Q1 2024 Earnings Release |
2024-05-21 07:00 am | EXSCIENTIA PLC: Q1 2024 Earnings Release |
2024-05-17 02:00 am | BIOARCTIC AB: Q1 2024 Earnings Release |
2024-05-15 04:05 pm | CULLINAN THERAPEUTICS, INC.: Q1 2024 Earnings Release |
2024-05-15 07:00 am | PERSPECTIVE THERAPEUTICS, INC.: Q1 2024 Earnings Release |
2024-05-14 | GNI GROUP LTD.: Q1 2024 Earnings Release |
2024-05-14 04:05 pm | KYVERNA THERAPEUTICS, INC.: Q1 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- ORGO Stock
- AHPAU Stock
- Calendar Organogenesis Holdings Inc.